Business · 04/10/2023Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 11 ANDAs from Dr. Reddy's Laboratories
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 11 abbreviated new drug applications (ANDAs) from Dr. Reddy's Laboratories, Inc., following a notification from the company that the affected drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →